Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya

Autor: Okumu, Albert, Orwa, James, Sitati, Ruth, Omondi, Isaiah, Odhiambo, Ben, Ogoro, Jeremiah, Oballa, George, Ochieng, Benjamin, Wandiga, Steve, Ouma, Collins

Publikováno v: In Journal of Clinical Tuberculosis and Other Mycobacterial Diseases December 2024 37

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis : The Case of Kenya

Autor: Masini, Enos, Hanson, Christy, Ogoro, Jeremiah, Brown, Jessie, Ngari, Faith, Mingkwan, Pia, Makayova, Julia, Osberg, Mike

Publikováno v: The Journal of Infectious Diseases, 2017 Oct 01. 216, S714-S723.

Externí odkaz: https://www.jstor.org/stable/26491593

Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries.

Autor: Aguiar Soares K; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain., Ehrlich J; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain., Camará M; Programa Nacional de Luta Contra Lepra e Tuberculose, Bissau, Guinea-Bissau., Chaloub S; Guinée Médecins Sans Frontières, Conakri, Guinea., Emeka E; National Tuberculosis and Leprosy Control Programme, Abuja, Nigeria., Gando HG; Service de Lutte Contre la Tuberculose, Bangui, Central African Republic., Ismail F; Centre for Tuberculosis, National Institute for Communicable Diseases/National Health Laboratory Services, Johannesburg, South Africa., Mvusi L; TB Control and Management, National Department of Health, Pretoria, South Africa., Jele T; National Tuberculosis Control Programme, Manzini, Eswatini., José B; Programa Nacional de Controlo da Tuberculose, Maputo, Mozambique., Kgwaadira B; Botswana National Tuberculosis Programme, Gaborone, Botswana., Kisonga R; National Tuberculosis and Leprosy Programme, Dar Es Salaam, United Republic of Tanzania., Letta T; National Tuberculosis and Leprosy Programme, Addis Ababa, Ethiopia., Liega AO; Programme National de Lutte Contre la Tuberculose, Brazzaville, Congo., Lungu PS; National Tuberculosis and Leprosy Control Programme, Lusaka, Zambia., Maama L; National Tuberculosis and Leprosy Programme, Maseru, Lesotho., Mahoumbou J; Programme National de Lutte Contre la Tuberculose, Libreville, Gabon., Mbendera K; National Tuberculosis Control Programme, Lilongwe, Malawi., Ogoro J; National Tuberculosis, Leprosy and Lung Disease Programme, Nairobi, Kenya., Tollo DAD; Programme National de Lutte Contre la Tuberculose, Yaoundé, Cameroon., Sandy C; Ministry of Health and Child Care, Harare, Zimbabwe., Saye RG; National Leprosy and Tuberculosis Control Programme, Monrovia, Liberia., Sheehama J; University of Namibia, Windhoek, Namibia., Musala S; Programme National de Lutte Contre la Tuberculose, Kinshasa, Democratic Republic of the Congo., Tugumisirize D; Ministry of Health - National Tuberculosis Reference Laboratory, Kampala, Uganda., Carratala L; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain., Cossa M; Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique., Garcia-Basteiro AL; ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain alberto.garcia-basteiro@manhica.net.; Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Publikováno v: The European respiratory journal [Eur Respir J] 2023 Oct 19; Vol. 62 (4). Date of Electronic Publication: 2023 Oct 19 (Print Publication: 2023).